ArticleSignal transduction and targeted therapy2021

Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.

Guoxu Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.